Alumis
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
About Alumis
Alumis develops precision medications to treat autoimmune illnesses. The company's analytics platform and understanding of immunologic disorders aid in the development of treatments and medications for autoimmune diseases, allowing patients to alleviate suffering and modify their way of life.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $917,194,730
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-07
- Website
- alumis.com
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Precision Medicine
Social Links
Canonical: https://fsome.com/organization/alumis-22589 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.